In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors

Bioorganic & Medicinal Chemistry
2016.0

Abstract

Herein we report the synthesis, PDE-4B and TNF-α inhibitory activities of a few dibenzo[b,d]furan-1-yl-thiazole derivatives. The hydroxycyclohexanol amide derivatives 14, 18, 24, 29, 31 and 33 exhibited promising in vitro PDE-4B and TNF-α inhibitory activities. Compound 24 showed good systemic availability in preclinical animal models and was also found to be non-toxic (exploratory mutagenicity test). Further it exhibited promising results in in vivo asthma/COPD and Uveitis models.

Knowledge Graph

Similar Paper

In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors
European Journal of Medicinal Chemistry 2020.0
Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Novel Selective PDE4 Inhibitors. 3. In Vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
Journal of Medicinal Chemistry 2002.0
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 2000.0
Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma
Medicinal Chemistry Research 2012.0
Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors
ACS Medicinal Chemistry Letters 2020.0